Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells

Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells
复制标题

DOI:
10.1111/j.1365-2443.2005.00821.x
复制
发表时间:
2005-02-01
期刊:
影响因子:
2.1
通讯作者:
Yano, J
Yano, J
中科院分区:
生物学4区
文献类型:
--
作者:
Takagaki, K;Katsuma, S;Yano, J

文献摘要

被引文献

相似文献

人慢性髓性白血病K562细胞对抗代谢物阿糖胞苷(Ara-C)具有相对抗性,并且当用Ara-C处理时,它们分化成红细胞而不经历凋亡。本研究探讨了阿糖胞苷诱导K562细胞分化的机制。我们首先观察到,Ara-C诱导的这些细胞的分化完全抑制的放射增敏剂咖啡因,ATM和ATR蛋白激酶的抑制剂。我们接下来发现,Ara-C激活细胞中的Chk 1和Chk 2,并且Chk 1的激活几乎完全被咖啡因抑制,而不是Chk 2。蛋白酶体介导的Cdc 25 A的降解和Cdc 25 C的磷酸化诱导Ara-C处理,推测是由于Chk 2和Chk 1的激活,分别。为了直接观察检查点激酶激活在Ara-C诱导分化中的作用,我们用Chk 1特异性抑制剂Go 6976抑制Chk 1或Chk 2,通过产生稳定过表达Chk 2的显性阴性形式的细胞系,或通过siRNA介导的Chk 1或Chk 2基因敲低。结果提示,阿糖胞苷诱导K562细胞向红系分化依赖于Chk 1和Chk 2两条途径。
Human chronic myelogenous leukemia K562 cells are relatively resistant to the anti-metabolite cytosine arabinoside (Ara-C) and, when treated with Ara-C, they differentiate into erythrocytes without undergoing apoptosis. In this study we investigated the mechanism by which Ara-C induces K562 cells to differentiate. We first observed that Ara-C-induced differentiation of these cells is completely inhibited by the radiosensitizing agent caffeine, an inhibitor of ATM and ATR protein kinases. We next found that Ara-C activates Chk1 and Chk2 in the cells, and that the activation of Chk1, but not of Chk2, was almost completely inhibited by caffeine. Proteasome-mediated degradation of Cdc25A and phosphorylation of Cdc25C were induced by Ara-C treatment, presumably due to the activation of Chk2 and Chk1, respectively. To directly observe the effects of checkpoint kinase activation in Ara-C-induced differentiation, we suppressed Chk1 or Chk2 with the Chk1-specific inhibitor Go6976, by generating cell lines stably over-expressing dominant-negative forms of Chk2, or by siRNA-mediated knock-down of the Chk1 or the Chk2 gene. The results suggest that Ara-C-induced erythroid differentiation of K562 cells depends on both Chk1 and Chk2 pathways.